Not independent
Tenure on this board
9.8 yrs
Also a director at
Sotera Health Co (SHC)
Meeting calendar
HAE · Annual meeting · Thursday, July 24, 2025
Haemonetics Corp
9 nominees · 3 ballot items.
Election of the nine director nominees, advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor for the 2026 fiscal year.
Market cap
$3.4B
1Y TSR
+3.7%
Board grade
B
Record date
May 27, 2025
Filing
DEF 14A
Meeting concluded · Jul 24, 2025
Follow how the vote landed and what changed on Haemonetics Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of nine director nominees named in this Proxy Statement for one-year terms expiring in 2026
ManagementBoard: FORElection of the nine director nominees to serve one-year terms expiring at the 2026 Annual Meeting of Shareholders.
- 2
Advisory Vote on Executive Compensation
ManagementBoard: FORAdvisory, non-binding vote to approve the compensation of Haemonetics Corporation’s Named Executive Officers, as disclosed in this Proxy Statement.
- 3
Ratification of Ernst & Young LLP as Haemonetics’ independent registered public accounting firm for the fiscal year ending March 28, 2026
ManagementBoard: FORRatify Ernst & Young LLP as Haemonetics’ independent registered public accounting firm for fiscal 2026.
Director elections
Nominees on the ballot9
Independent
Tenure on this board
8.7 yrs
Also a director at
Avient Corp (AVNT)
Independent
Tenure on this board
2.9 yrs
Also a director at
Broadcom Inc (AVGO)
Independent
Tenure on this board
6.2 yrs
Also a director at
Integer Holdings Corp (ITGR)
Independent
Tenure on this board
11.9 yrs
Also a director at
Keysight Technologies Inc (KEYS)
Independent
Tenure on this board
4.9 yrs
Also a director at
Apogee Enterprises Inc (APOG)Beazer Homes USA Inc (BZH)Vse Corp (VSEC)
Independent
Tenure on this board
20.5 yrs
Independent
Tenure on this board
7.2 yrs
Also a director at
Embecta Corp (EMBC)
Independent
Tenure on this board
8.4 yrs
Also a director at
Boston Scientific Corp (BSX)Synchrony Financial (SYF)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Neuberger Berman Group LLC | 7.8% | 3,560,918 | $201M |
| 2 | BlackRock, Inc. | 7.8% | 3,538,566 | $199M |
| 3 | AQR CAPITAL MANAGEMENT LLC | 7.3% | 3,327,929 | $184M |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.6% | 2,559,316 | $144M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6% | 2,090,389 | $118M |
| 6 | STATE STREET CORP | 3.9% | 1,772,898 | $100M |
| 7 | BlackRock, Inc. | 3.4% | 1,529,974 | $86M |
| 8 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.0% | 1,383,004 | $78M |
| 9 | River Road Asset Management, LLC | 2.9% | 1,327,989 | $75M |
| 10 | DIMENSIONAL FUND ADVISORS LP | 2.7% | 1,210,688 | $68M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Haemonetics Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Catalyst Pharmaceuticals IncCPRX
Special meeting·Jul 8, 2026·$3.8B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.2B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$2.0B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.9B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.5B
Reference
Frequently asked questions
- When is the Haemonetics Corp 2025 annual meeting?
- Haemonetics Corp (HAE) holds its 2025 annual shareholder meeting on Thursday, July 24, 2025.
- What is the record date for the Haemonetics Corp 2025 meeting?
- The record date for the Haemonetics Corp 2025 meeting is Tuesday, May 27, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Haemonetics Corp's 2025 meeting?
- The board is presenting 9 director nominees at the Haemonetics Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Haemonetics Corp 2025 meeting?
- Shareholders will vote on 3 proposals at the Haemonetics Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.